Sunscreen labels may still be confusing to majority of consumers
the ONA take:
According to results of a small study published online ahead of print in JAMA Dermatology, researchers have found that sunscreen labels may still be confusing to the majority of consumers.
For the study, researchers from Northwestern University Feinberg School of Medicine in Chicago surveyed 114 patients at a single dermatology clinic to evaluate their understanding of sunscreen labels and best practices for sun protection.
Results showed that 81.6% reported purchasing sunscreen in 2013. Of all participants, 75.4% said they purchased sunscreen in order to prevent sunburns and 65.8% bought it to prevent skin cancer.
Researchers found that only 43% understood the definition of SPF, 37.7% could correctly determine how well the sunscreen protected against skin cancer, and 22.8% could correctly identify how well the sunscreen protected against sunburns.
The findings suggest that sunscreen label terminology may still be confusing to the majority of consumers seeking to protect themselves from sunburns and skin cancer.
Sunscreen labels may still be confusing to the majority of consumers.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|